Patient derived neuroblastoma cell lines are excellent tools to study biology of the disease. While many previous studies sequenced neuroblastoma cell lines, there are very few ALT and non-<a href="https://www.ncbi.nlm.nih.gov/gene/4613">MYCN</a>-amplified neuroblastoma cell lines that were sequenced previously. Here, we present raw RNA sequencing data for 3 ALT (CHLA-90, SK-N-FI, COG-N-515) and 8 non-MYCN-amplified telomerase positive (CHLA-171, Felix, COG-N-579h, COG-N-615, COG-N-618h, COG-N-619h, COG-N-708h, COG-N-709) neuroblastoma cell lines. Additionally, gene expression data are provided as a supplement files.

Transcriptomic Profiling of Patient Derived Alternative Lengthening of    Telomeres (ALT) and Non-MYCN-Amplified Neuroblastoma Cell Lines

Variables — phs002421 — Transcriptomic Profiling of Patient Derived Alternative Lengthening of    Telomeres (ALT) and Non-MYCN-Amplified Neuroblastoma Cell Lines

Transcriptomic Profiling of Patient Derived Alternative Lengthening of Telomeres (ALT) and Non-MYCN-Amplified Neuroblastoma Cell Lines

Demographics (2)

Other (12)